abuse liability assessment of the JUUL system in four flavors relative to combustible cigarette, nicotine gum and a comparator electronic nicotine delivery system among adult smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Goldenson (2020)
an Open-Label, Randomized, Controlled, Crossover Study to assess Nicotine Pharmacokinetics and Subjective Effects of the JUUL System with Three Nicotine Concentrations Relative to Combustible Cigarettes in adult Smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Goldenson (2021)
association Between E-Cigarette Use and Visual Impairment in the United States.
Individual Clinical
Safety
Adverse Effects
Golla (2022)
Electronic Cigarettes are a Source of Thirdhand Exposure to Nicotine
Individual Clinical
Respiratory Toxicity
Secondary & Tertiary
Exposure
Goniewicz (2014)
Exposure to Nicotine and Selected Toxicants in Cigarette Smokers Who Switched to Electronic Cigarettes: a Longitudinal Within-Subjects Observational Study
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Goniewicz (2017)
Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes
Individual Clinical
Biomarkers
Biomarkers Of Exposure
Goniewicz (2018)
high exposure to nicotine among adolescents who use Juul and other vape pod systems ('pods’).
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Goniewicz (2019)
Biomarkers of Electronic Nicotine Delivery Systems (ENDS) use.
Individual Clinical
Biomarkers
ALL
Goniewicz (2023)
acute effects of electronic cigarettes on arterial pressure and peripheral sympathetic activity in young nonsmokers.
Individual Clinical
Safety
Adverse Effects
Gonzalez (2021)
Electronic Cigarette Use and Metabolic Syndrome Development: a Critical Review.
Individual Clinical
Safety
Adverse Effects
Górna (2020)